Jun 1, 2026 07:26AM
Jun 1, 2026 06:55AM
May 29, 2026 03:06PM
May 29, 2026 03:05PM
May 29, 2026 02:54PM
May 7, 2026 05:59AM
May 7, 2026 04:57AM Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
May 1, 2026 04:00AM
Jan 6, 2026 08:00AM
Dec 19, 2025 07:42AM
Oct 7, 2025 06:39AM
Aug 22, 2025 05:33AM
Apr 15, 2025 03:01PM
Apr 10, 2025 08:04AM Oculis Holding (OCS) Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema
Apr 10, 2025 08:00AM
Apr 1, 2025 04:00AM
Mar 13, 2025 06:41AM
Mar 12, 2025 09:18AM
Jan 7, 2025 06:52AM
Jan 6, 2025 02:12PM
Aug 28, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Oculis Holding AG (OCS)
Aug 27, 2024 04:00AM
Jun 11, 2024 06:42AM
Jun 11, 2024 05:24AM
Jun 10, 2024 05:00AM
Jun 10, 2024 04:30AM
Apr 10, 2024 06:30AM
Dec 20, 2023 06:30AM Oculis Announces First Patient First Visit in Phase 3 OPTIMIZE-2 Trial of OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery
Aug 8, 2023 06:30AM
Aug 8, 2023 06:30AM
Apr 26, 2023 07:04AM
Apr 26, 2023 07:00AM
Apr 26, 2023 07:00AM

323,580 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All